Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- The entries summarize the cited US FDA labels for the named products and their distinct approved indications.
- Victoza: Initiate 0.6 mg SC daily × 1 wk, then 1.2 mg daily; may increase to 1.8 mg daily if additional glycemic control needed.
- Saxenda: Initiate 0.6 mg SC daily, titrate weekly (0.6 mg increments) to 3.0 mg daily maintenance. Not interchangeable with Victoza.